Loading

International Journal of Clinical Anesthesiology

Use of Dexmedetomidine in Veterinary Practice

Short Note | Open Access

  • 1. School of Biosciences and Veterinary Medicine, University of Camerino, Italy
+ Show More - Show Less
Corresponding Authors
Scrollavezza Paolo, Retired Professor from School of Biosciences and Veterinary Medicine, University of Camerino, Italy, Tel: 393387974266
Citation

Paolo S (2017) Use of Dexmedetomidine in Veterinary Practice. Int J Clin Anesthesiol 5(4): 1078.

INTRODUCTION

A variety of alpha2 adrenoceptor agonists - xylazine, detomidine, romifidine, medetomidine (MED) and dexmedetomidine (DEX) - have been developed in veterinary medicine for sedative purpose. The tranquilizing and muscle relaxant effects of these substances differ primarily because of their alpha-2: alpha-1 affinity on central nervous noradrenergic receptors (maximum for dexmedetomidine, minimum for xylazine) in a dose-dependent way in small and large animal. The analgesic and anxiolytic effects of alpha2 agonists is due to different mechanisms of action in the different animal species, and is not proportional to the tranquilizing effect. In general, the sedative and analgesic effects of alpha2 agonists are dosedependent at low dosage; at high dosage, there is an upper limit on the degree of analgesia, while the sedation increase only in duration [1,2]. The adverse effects are also dose-dependent, especially the reduction in blood pressure and heart output [3]. In most animal species, dexmedetomidine (the active enantiomer of medetomidine) have replaced the other alpha2 agonists because the higher receptor selectivity making its effect more predictable. Moreover, its anesthetic and collateral effects may be completely antagonized with a specific antidote (atipamezole) [4,5]. The sedative DEX activity is two times potent than MED and with less side effects [6]. In the cat only, the muscular relaxation induced by MED seems deeper [7]. The dosages of DEX are one half the dosage for racemic MED, but the concentration of DEX [0.5 mg/ml] is half that of MED [1 mg/ml]; therefore, the dosage volumes are the same for both commercial products (Dexdomitor and Domitor).

DOG AND CAT

DEX and MED commercial products are labeled for use in dog and cat only. In ASA class I or II dogs and cats, the restraint dosage of MED causes side effects a little more serious than the equipotent dosage of DEX [8]. Then, from a clinical point of view, it is difficult to assess whether a dog or cat have been received sedation with MED or equivalent dose of DEX. In ASA III or IV, where the patient has severe systemic disturbances or systemic disease is life-threatening, the use of DEX is not recommended because its important adverse effects, especially on cardio circulatory and respiratory system [9-11]. For this reason and to minimize the overall adverse effects, administer low doses of DEX in conjunction with other agents (dissociatives, opioids, tramadol) as part of an anesthetic balanced regimen, it’s a good choice normally used by vets in dog and cat as well as in other species [12,13]. DEX can also enhance the analgesic effects of other agents given epidurally in the dog. It acts in synergy with opioids and local anesthetics, improving the quality and duration of analgesia [14,15]. DEX is absorbed by epidural space, increasing the effects of other sedatives used to permit epidural injection.

USE OF DEXMEDETOMIDINE IN OTHER ANIMALS

DEX is labeled for using only in dog and cat, but due to its potency, the small volume necessary to produce sedation, the synergic effect with other anesthetic substances and the possibility to reverse completely sedative and collateral effects with a specific antidote, DEX is utilized widely by vets in other domestic and not domestic animal.

Horse

DEX is used in standing chemical restraint as a part of a balanced anesthesia or in Total Intravenous Anesthesia (TIVA) [16,17]. Standing chemical restraint becomes necessary when general recumbent anesthesia is hazardous for the horse (i.e. pregnancy or severe respiratory problem), or when the operator have to perform diagnostic or surgery procedures keeping the anatomic planes in a physiological position (i.e. abdominal endoscopy or laryngeal surgery, as shown in Figure 1 and Figure 2). The balanced anesthesia in standing chemical restraint is obtained with a combination of DEX and opioid. DEX is to prefer to the other alpha2 agonists because the high potency, especially on the opioid brain receptors. This results in a synergistic effect, leading to improved quality and duration of analgesia. TIVA is an effective method of providing field anesthesia and anesthesia for short procedures in the practice setting. TIVA is obtained with DEX in conjunction with many substances like dissociatives, opioids, propofol, guaifenesin or tramadol by intravenous route. Depending on the need, these anesthetics can be injected one at a time, mixed in the same syringe or in constant rate infusion. In this species DEX can also be used intraarticularly because alpha-2 agonists are also distributed on the terminal ends of primary afferent nociceptive fibers [18]. The combination of DEX and a local anesthetic (i.e. bupivacaine or mepivacaine) is then used to provide long term analgesia when given in the joint after arthroscopy or arthrotomy [19,20].

Ruminant

Medetomidine, dexmedetomidine and detomidine induces severe collateral effects in adult cattle [21]. Therefore, the oldest alpha-2 agonists xylazine is preferred to produces sedation in these animals. In small ruminants (sheep, goat, alpaca, llama and calf) DEX is used in standing chemical restraint with tramadol or opioids as a part of balanced anesthesia [22-24]. In combination with intramuscular ketamine, DEX works very well in these animals to obtain short recumbent anesthesia. Prolonged recumbent anesthesia with TIVA or inhalants can be complicated and life threatening because of their unusual anatomy and physiology.

Swine

In domestic animals, swine is the most resistant to sedative drugs. DEX can be intramuscular administered in combination with a particular tranquilizer (azaperone) and dissociatives to produce deep sedation and smooth induction of inhalant anesthesia [25,26].

Non-Domestic Animal

The presence of alpha2 adrenoreceptor in the central nervous system is a constant in animal species. Therefore, administration of an alpha2 adrenoceptor agonists always gives a sedative effect in the majority of animal species. In small animal species (i.e. birds, rabbits, tortoises, snakes) DEX is right and proper because it is very powerful and need a small volume to give sedative effect [27-31]. The small volume it’s also important because it’s necessary to inject small quantity of liquid in the little muscles of these particular animals. MED and DEX can be mixed in the same syringe without chemical interaction with all the other drugs necessary to perform balanced anesthesia [32].

Small volume and efficacy is in fact a primary need when veterinarianshave to charge a small syringe to capture a wild or unapproachable animal with teleanesthesia. For example, mixing Dexdomitor 2,5 ml and Ketavet 100 2,5 ml can immobilize in few seconds a 100-kg deer using remote injection with a dart gun [33].

REFERENCES

1. Virtanen R. Pharmacology of detomidine and other alpha 2-adrenoceptor agonists in the brain. Acta Vet Scand Suppl. 1986; 82: 35-46.

2. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988; 150: 9-14.

3. Murrell JC, Hellebrekers LJ. Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog. Vet Anaesth Analg. 2005; 32: 117-127.

4. Granholm M, McKusick BC, Westerholm FC, Aspegrén JC. Evaluation of the clinical efficacy and safety of intramuscular and intravenous doses of dexmedetomidine and medetomidine in dogs and their reversal with atipamezole. Vet Rec. 2007; 160: 891-897.

5. Granholm M, McKusick BC, Westerholm FC, Aspegrén JC. Evaluation of the clinical efficacy and safety of intramuscular and intravenous doses of dexmedetomidine and medetomidine in dogs and their reversa. Vet Rec. 2007; 160: 891-897.

6. Doze VA, Chen B-X, Li Z, Maze M. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine. Acta Vet Scand Suppl. 1989; 85: 61-64.

7. Scrollavezza P, Tambella AM, Vullo C, Piccionello AP. Evaluation of the muscular relaxant effect of dexmedetomidine or medetomidine in cats. Vet Res Commun. 2009; 33: 213-215.

8. Kuusela E, Raekallio M, Väisänen M, Mykkänen K, Ropponen H, Vainio O. Comparison of medetomidine and dexmedetomidine as premedicants in dogs undergoing propofol-isoflurane anesthesia. Am J Vet Res. 2001; 62: 1073-1080.

9. Bloor BC, Frankland M, Alper G, Raybould D, Weitz J, Shurtliff M. Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther. 1992; 263: 690-697.

10. Hunt JR, Slingsby LS, Murrell JC. The effects of an intravenous bolus of dexmedetomidine following extubation in a mixed population of dogs undergoing general anaesthesia and surgery. Vet J. 2014; 200: 133-139.

11. Sinclair MD. A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J. 2003; 44: 885-897.

12. Barletta M, Austin BR, Ko JC, Payton ME, Weil AB, Inoue T. Evaluation of dexmedetomidine and ketamine in combination with opioids as injectable anesthesia for castration in dogs. J Am Vet Med Assoc. 2011; 238: 1159-1167.

13. Cardoso CG, Marques DR, da Silva TH, De Mattos-Junior E. Cardiorespiratory, sedative and antinociceptive effects of dexmedetomidine alone or in combination with methadone, morphine or tramadol in dogs. Vet AnaesthAnalg. 2014; 41: 636-643.

14. Sullivan AF, Kalso EA, McQuay HJ, Dickenson AH. The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat. Eur J Pharmacol. 1992; 215: 127-133.

15. Ossipov M, Harris S, Lloyd P, Messineo E, Lin BS, Bagley J. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology. 1990; 73: 1227-1235.

16. Rezende ML, Grimsrud KN, Stanley SD, Steffey EP, Mama KR. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in the horse. J Vet Pharmacol Ther. 2015; 38: 15-23.

17. Hopster K, Müller C, Hopster-Iversen C, Stahl J, Rohn K, Kästner S. Effects of dexmedetomidine and xylazine on cardiovascular function during total intravenous anaesthesia with midazolam and ketamine and recovery quality and duration in horses. Vet Anaesth Analg. 2014; 41: 25-35.

18. Kim WH, Cho D, Lee B, Song JJ, Shin TJ. Changes in brain activation during sedation induced by dexmedetomidine. J Int Med Res. 2017; 45: 1158-1167.

19. Al-Metwalli RR, Mowafi HA, Ismail SA, Siddiqui AK, Al-Ghamdi AM, Shafi MA, et al. Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic knee surgery. Br J Anaesth. 2008; 101: 395-399.

20. Panigrahi R, Roy R, Mahapatra AK, Prasad A, Priyadarshi A, Palo N. Intra-articular adjuvant analgesics following knee arthroscopy: comparison between single and double dose dexmedetomidine and ropivacaine: a multicenter prospective double-blind trial. Orthop Surg. 2015; 3: 250-255.

21. Ranheim B, Søli NE, Ryeng KA, Arnemo JM, Horsberg TE. Pharmacokinetics of medetomidine and atipamezole in dairy calves: an agonist-antagonist interaction. J Vet Pharmacol Ther. 1998; 21: 428-432.

22. Seddighi R, Odoi A, Doherty TJ. Effect of dexmedetomidine hydrochloride on tiletamine hydrochloride-zolazepam hydrochloride anesthesia in alpacas. Am J Vet Res. 2016; 77: 1057-1063.

23. Cagnardi P, Villa R, Ravasio G, Lucatello L, Di Cesare F, Capolongo F, et al. Pharmacokinetics and sedative effects of dexmedetomidine in dairy calves. N Z Vet J. 2017; 65: 14-18.

24. Borges LP, Nishimura LT, Carvalho LL, Cerejo SA, Auckburally A, Mattos-Junior E. Behavioral and cardiopulmonary effects of dexmedetomidine alone and in combination with butorphanol, methadone, morphine or tramadol in conscious s... Vet Anaesth Analg. 2016; 43: 549-560.

25. Linkenhoker JR, Burkholder TH, Linton CG, Walden A, Abusakran Monday KA, Rosero AP, et al. Effective and safe anesthesia for yorkshire and yucatan swine with and without cardiovascular injury and intervention. J Am Assoc Lab Anim Sci. 2010; 49: 344-351.

26. Santos M, Bertrán de Lis BT1, Tendillo FJ. Effects of intramuscular dexmedetomidine in combination with ketamine or alfaxalone in swine. Vet Anaesth Analg. 2016; 43: 81-85.

27. Ter Beest J, Mc Clean M, Cushing A, Bildfell R. Thiafentanil dexmedetomidine-telazol anesthesia in greater rheas (Rhea americana). J Zoo Wildl Med. 2012; 43: 802-807.

28. Santangelo B, Micieli F, Marino F, Reynaud F, Cassandro P, Carfora A, et al. Plasma concentrations and sedative effects of a dexmedetomidine, midazolam, and butorphanol combination after transnasal administration in healthy rabbits. J Vet PharmacolTher. 2016; 39: 408-411.

29. Terada Y, Ishiyama T, Asano N, Kotoda M, Ikemoto K, Shintani N, et al. Optimal doses of sevoflurane and propofol in rabbits. BMC Res Notes. 2014; 7: 820.

30. Harms CA, Piniak WE, Eckert SA, Stringer EM. Sedation and anesthesia of hatchling leatherback sea turtles (Dermochelyscoriacea) for auditory evoked potential measurement in air and in water. J Zoo Wildl Med. 2014; 45: 86-92.

31. Craig A.E. Mosley. Anesthesia andanalgesia in reptiles.Seminars in Avian and Exotic Pet Medicine. 2005; 14: 243-262.

32. Dodd J. Zoo Animal and Wildlife Immobilization and Anesthesia. Can Vet J. 2010; 51: 622.

33. Bouts T, Taylor P, Berry K, Routh A, Gasthuys F. Evaluation of medetomidine-ketamine and dexmedetomidine-ketamine in Chinese water deer (Hydropotes inermis). Vet Anaesth Analg. 2011; 38: 106- 112.

Received : 30 Jun 2017
Accepted : 26 Jul 2017
Published : 27 Jul 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X